Embody vs Shed: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Shed beats Embody overall, scoring 7.8/10 vs 7.3/10. Embody is more affordable at $149/mo vs $199/mo. Choose Embody for people who want the oral tirzepatide gum, or who'll choose t. Choose Shed for users who want fast delivery and a streamlined compounded gl.
A side-by-side look at Embody and Shed to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Embody
#37 of 52Online weight-loss program that ships compounded GLP-1 medication to your door. Run by Modern Metabolic Medicine, Inc. and prescribed through CareGLP Affiliated P.C.s, their network of licensed doctors. Two pricing plans run side by side: a promo plan starting at $99/mo for semaglutide (or $149/mo for tirzepatide) that jumps after month 1, and 'Embody Flat' at $299/mo that doesn't go up. Their standout: oral tirzepatide gum, for people who don't want to inject.
Visit EmbodyShed
#15 of 52Newer GLP-1 provider focused on speed and simplicity, fast approvals, fast shipping, and a clean user experience at a competitive price point.
Visit Shed| Feature | Embody | Shed |
|---|---|---|
| Our Score | 7.3/10 | 7.8/10 |
| Starting Price | $149/mo | $199/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | People who want the oral tirzepatide gum, or who'll choose the $299/mo 'Embody Flat' plan at signup for one predictable price | Users who want fast delivery and a streamlined compounded GLP-1 experience |
| Ranking | #37 | #15 |
| Get started | Visit Embody | Visit Shed |
Pros & Cons Compared
Embody
Pros
- +Oral tirzepatide gum is rare. Real option for needle-phobic users. (How well it absorbs vs the FDA-approved injection isn't published.)
- +Cheap first month, $99 for semaglutide or $149 for tirzepatide. Among the lowest entry prices in the category.
- +'Embody Flat' plan is $299/mo flat with no surprise increases, predictable if you pick it from the start.
- +100% money-back guarantee in writing: if you follow the program and don't see results in 6 months, they say they'll make it right.
- +Replies to every negative Trustpilot review, usually within 24 hours.
Cons
- −Two plans run side by side and the switchover isn't always clear at signup: the $149 promo month steps up to $299–$399 from month 2 (Embody confirms both plans in its review replies). Pick 'Embody Flat' at signup if you want one predictable number.
- −Trustpilot rating is a polarized 3.3 / 5 across 46 reviews: 41% five-star, 24% one-star. Price is the top complaint theme, most of it tied to the promo-to-flat switchover above.
- −Embody doesn't name which pharmacy makes the medication, just 'multiple USA certified pharmacies.' This is the norm in the category, most major brands (Embody, Henry, Hims, Yucca, Eden) don't publicly name their pharmacy partners; ask support directly if provenance matters to you.
- −No HIPAA disclosure on their site (HIPAA is the federal law protecting your medical info, most telehealth providers publish a statement confirming they follow it).
- −Compounded medications only, no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic available.
- −If you stop treatment and come back, Embody's doctors will likely restart you at the lowest dose (2.5mg). It's their safety policy; raise your dose history at signup, the prescriber makes the final call.
Shed
Pros
- +Industry-leading delivery speed, most patients receive medication within 2-3 days of enrollment
- +$199/mo is competitively priced for an all-inclusive compounded program with good support
- +Streamlined onboarding with no video call, approved and shipped faster than most competitors
- +Clean, modern UX with real-time shipping tracking and easy provider messaging
Cons
- −The core $199 program is compounded semaglutide and tirzepatide; brand-name access runs through a separate $99/mo pathway subscription with medication billed at pharmacy rates on top
- −Newer company (founded 2024) with limited long-term track record and outcome data; the 4.6/5 Trustpilot rating across 766 reviews is the strongest early evidence available
- −No insurance billing and no FSA/HSA superbills currently available
- −Clinical support is responsive (replies typically within 24 hours) but less proactive than premium platforms; a $49.99/mo premium coaching add-on covers those who want higher touch
Our Verdict
Shed edges out Embody with a score of 7.8/10 vs 7.3/10. If budget is your priority, Embody starts at $149/mo compared to Shed's $199/mo. Shed offers both brand-name and compounded medications, giving you more flexibility. Choose Embody if you want: people who want the oral tirzepatide gum, or who'll choose the $299/mo 'embody flat' plan at signup for one predictable price. Choose Shed if you want: users who want fast delivery and a streamlined compounded glp-1 experience.
Still undecided? Editor's Featured Pick
Yucca Health
$146/mo · 7.7/10 · Compounded
If neither Embody nor Shed feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.
Read Full Reviews
Related comparisons
Other matchups readers comparing Embody or Shed tend to look at next.
- Embody vs TrimRx$149/mo
- Embody vs Strut Health$149/mo
- Embody vs Maximus$150/mo
- Shed vs MEDVi$179/mo
- Shed vs Henry Meds$199/mo
- Shed vs GobyMeds$169/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.